How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Close this folder8 EVALUATION
View the documentEvaluation of the NF within the framework of existing monitoring and evaluation activities
View the documentHow to design the evaluation
Open this folder and view contentsWhat to evaluate
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

How to design the evaluation

Evaluation of the NF will require standards and processes similar to those for a research project. These include:

- defining the scope and questions to be answered by the evaluation;
- selecting or developing the appropriate methods and testing data collection instruments;
- collecting and analysing the data; and
- interpreting results and


Depending on the objective of the evaluation, the types of information collected may include:

Descriptive information (specific information obtained from close-ended questions) e.g. Is there a national policy to endorse the regular production and dissemination of the NF, Yes or No):?

Quantitative information (numbers): e.g. What percentage of prescribers in a health facility have a personal copy of the NF?

Qualitative information (statements, opinions): e.g. Why do prescribers use (or not use) the NF regularly?


A valid evaluation requires the collection of the right amount of relevant information. Some practical hints on how to avoid common pitfalls of evaluations are offered in Table 8.1.

Table 8.1. Useful hints for planning and conducting an evaluation

Dos

Don'ts

Make sure to involve important partners in the design of the evaluation.

Do not treat evaluation as a trivial task after production of a NF.

Consider carefully the available resources when deciding on depth and complexity of evaluation.

Do not be over ambitious.

Ask important questions that matter for future production and measuring the impact of the NF.

Do not collect data unless they are needed to answer the questions identified.

Make sure that data collection tools and indicators are reliable, i.e. that they measure what they are intended to.

Do not try to gather information that is very difficult to obtain.

Make sure that results of the evaluation are disseminated to all relevant decision-makers to influence future strategies and plans.

Do not lock up results and forget about them.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014